Shawcross DL

Faecal microbiota transplant restores intestinal barrier function and augments ammonia metabolism in patients with cirrhosis: a randomised single-blind placebo-controlled trial

Shawcross D, Edwards L, Woodhouse C, ..., Shoaie S, Goldenberg S

- - (-) - [2023-07-13; online 2023-07-13]

Saeed Shoaie SciLifeLab Fellow

Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial.

Patel VC, Lee S, McPhail MJW, ..., Shoaie S, Shawcross DL

J Hepatol 76 (2) 332-342 [2022-02-00; online 2021-09-24]

Saeed Shoaie SciLifeLab Fellow